{"filings":[{"id":1508756,"accession_number":"0001104659-26-081590","cik":1898718,"company_name":"GMR Solutions Inc.","ticker":"GMRS","form_type":"8-K/A","filed_at":"2026-07-08T12:33:09+00:00","items":["5.02"],"status":"ready","headline":"GMR Solutions amends 8-K to finalize Jan Stern Reed's board committee assignments","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Jan Stern Reed appointed to Board effective May 12, 2026, per original 8-K.","As of July 1, 2026, she serves as Chair of the Nominating, Corporate Governance and Compliance Committee.","She also serves as a member of the Audit Committee."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"market_cap_usd":2799354376.2599998,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":1508758,"accession_number":"0001104659-26-081586","cik":1898718,"company_name":"GMR Solutions Inc.","ticker":"GMRS","form_type":"8-K","filed_at":"2026-07-08T12:31:16+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"GMR Solutions Strengthens Board with Appointments of Healthcare Leaders Dr. Amar Desai and Ellen Zane","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Dr. Amar Desai and Ellen Zane appointed to GMR Solutions Board effective July 1, 2026.","Desai previously President of Optum Integrated Care and CEO of Optum Health at UnitedHealth Group.","Zane is CEO Emeritus of Tufts Medical Center and serves on boards of Boston Scientific, Haemonetics, Synchrony Financial.","Each director received 9,972 RSUs under the 2026 Equity Incentive Plan, vesting on first anniversary.","Desai will serve on Nominating, Corporate Governance and Compliance Committee; Zane as Chair of Human Capital and Compensation Committee."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":2799354376.2599998,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":779476,"accession_number":"0001104659-26-068983","cik":1898718,"company_name":"GMR Solutions Inc.","ticker":"GMRS","form_type":"8-K","filed_at":"2026-06-01T20:45:55+00:00","items":["2.02","9.01"],"status":"ready","headline":"GMR Solutions Q1 revenue $1.46B (+6.6% YoY), net income $106M (+180% YoY), guides FY26 rev $5.9-6.2B","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net revenue $1,457.6M, up 6.6% YoY from $1,367.4M; net income $106.3M, up 179.7% YoY.","Adjusted EBITDA $305.1M, up 9.7% YoY from $278.1M.","FY2026 guidance: net revenue $5,890M-$6,180M, Adj. EBITDA $1,135M-$1,195M.","Strong liquidity >$1.1B; redeemed $250M preferred stock on March 6, 2026."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":2799354376.2599998,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":481597,"accession_number":"0001104659-26-062932","cik":1898718,"company_name":"GMR Solutions Inc.","ticker":"GMRS","form_type":"8-K","filed_at":"2026-05-18T10:15:01+00:00","items":["1.01","1.02","3.02","8.01","3.03","5.03","5.02","9.01"],"status":"ready","headline":"GMR Solutions completes 31.9M share IPO at $14.25 net; repays $670M debt and redeems $299.5M preferred","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["IPO of 31,914,893 shares of Class A common at $14.25 net per share (after underwriting discounts).","Net proceeds used to redeem $299.5M of Series B Preferred Stock and repay ~$670M of 2032 First Lien Term Loan.","Appointed Jan Stern Reed and Timothy Wicks as independent directors; each granted 12,334 RSUs.","Executives granted options (strike $15) and RSUs: CEO Loporcaro 1.36M options & 600K RSUs, CFO Tierney 271K options & 120K RSUs.","Private placement: $500M of warrants (33.3M at $15 each) sold to KKR, Ares, and HPS affiliates; exercises at $0.01."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":2799354376.2599998,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}